Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 3 studies | 28% ± 16% |
Insufficient scRNA-seq data for expression of CLCF1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 99% | 561.48 | 178 / 180 | 100% | 50.49 | 429 / 430 |
kidney | 100% | 1278.66 | 89 / 89 | 94% | 33.80 | 843 / 901 |
lung | 99% | 782.29 | 573 / 578 | 91% | 23.13 | 1051 / 1155 |
prostate | 98% | 659.47 | 241 / 245 | 89% | 11.39 | 445 / 502 |
esophagus | 95% | 669.08 | 1378 / 1445 | 91% | 17.57 | 167 / 183 |
intestine | 100% | 923.82 | 964 / 966 | 85% | 13.19 | 449 / 527 |
thymus | 100% | 909.30 | 651 / 653 | 84% | 27.56 | 508 / 605 |
uterus | 99% | 1548.97 | 169 / 170 | 84% | 21.17 | 385 / 459 |
pancreas | 87% | 311.92 | 284 / 328 | 94% | 34.75 | 167 / 178 |
breast | 100% | 477.28 | 457 / 459 | 81% | 11.89 | 903 / 1118 |
bladder | 100% | 629.57 | 21 / 21 | 79% | 17.58 | 399 / 504 |
stomach | 88% | 795.91 | 316 / 359 | 86% | 13.86 | 246 / 286 |
skin | 78% | 547.03 | 1407 / 1809 | 41% | 6.11 | 193 / 472 |
spleen | 100% | 698.04 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.89 | 1 / 1 |
adipose | 99% | 855.76 | 1197 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 765.50 | 1325 / 1335 | 0% | 0 | 0 / 0 |
liver | 36% | 158.42 | 81 / 226 | 50% | 9.37 | 204 / 406 |
adrenal gland | 76% | 409.01 | 196 / 258 | 9% | 1.41 | 21 / 230 |
heart | 75% | 398.16 | 647 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 59% | 6.58 | 17 / 29 |
peripheral blood | 53% | 153.93 | 489 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 51% | 5.35 | 23 / 45 |
brain | 7% | 44.74 | 190 / 2642 | 32% | 6.75 | 228 / 705 |
muscle | 12% | 27.16 | 95 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.12 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042531 | Biological process | positive regulation of tyrosine phosphorylation of STAT protein |
GO_0019221 | Biological process | cytokine-mediated signaling pathway |
GO_0002639 | Biological process | positive regulation of immunoglobulin production |
GO_0048711 | Biological process | positive regulation of astrocyte differentiation |
GO_0030890 | Biological process | positive regulation of B cell proliferation |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
GO_0048295 | Biological process | positive regulation of isotype switching to IgE isotypes |
GO_0007259 | Biological process | cell surface receptor signaling pathway via JAK-STAT |
GO_0030183 | Biological process | B cell differentiation |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0097058 | Cellular component | CRLF-CLCF1 complex |
GO_0097059 | Cellular component | CNTFR-CLCF1 complex |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0008083 | Molecular function | growth factor activity |
GO_0005127 | Molecular function | ciliary neurotrophic factor receptor binding |
GO_0005515 | Molecular function | protein binding |
GO_0005125 | Molecular function | cytokine activity |
Gene name | CLCF1 |
Protein name | Cardiotrophin-like cytokine factor 1 (B-cell-stimulating factor 3) (BSF-3) (Novel neurotrophin-1) (NNT-1) |
Synonyms | NNT1 BSF3 CLC |
Description | FUNCTION: In complex with CRLF1, forms a heterodimeric neurotropic cytokine that plays a crucial role during neuronal development (Probable). Also stimulates B-cells. Binds to and activates the ILST/gp130 receptor. . |
Accessions | Q9UBD9 ENST00000533438.1 [Q9UBD9-2] ENST00000312438.8 [Q9UBD9-1] |